DD120103A1 - - Google Patents
Info
- Publication number
- DD120103A1 DD120103A1 DD18714375A DD18714375A DD120103A1 DD 120103 A1 DD120103 A1 DD 120103A1 DD 18714375 A DD18714375 A DD 18714375A DD 18714375 A DD18714375 A DD 18714375A DD 120103 A1 DD120103 A1 DD 120103A1
- Authority
- DD
- German Democratic Republic
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD18714375A DD120103A1 (https=) | 1975-07-07 | 1975-07-07 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD18714375A DD120103A1 (https=) | 1975-07-07 | 1975-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD120103A1 true DD120103A1 (https=) | 1976-05-20 |
Family
ID=5500965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD18714375A DD120103A1 (https=) | 1975-07-07 | 1975-07-07 |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD120103A1 (https=) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021218895A1 (zh) | 2020-04-29 | 2021-11-04 | 正大天晴药业集团股份有限公司 | 针对PD-1和TGF-β的双功能蛋白 |
| WO2023046037A1 (zh) | 2021-09-24 | 2023-03-30 | 正大天晴药业集团股份有限公司 | 抗cd40抗体及其用途 |
| WO2024193516A1 (zh) | 2023-03-17 | 2024-09-26 | 百奥泰生物制药股份有限公司 | 抗ox40抗体在治疗炎症或免疫性疾病中的应用 |
| WO2025044937A1 (zh) | 2023-08-31 | 2025-03-06 | 正大天晴药业集团股份有限公司 | 靶向受体酪氨酸激酶样孤儿受体1的抗体及其应用 |
-
1975
- 1975-07-07 DD DD18714375A patent/DD120103A1/xx unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021218895A1 (zh) | 2020-04-29 | 2021-11-04 | 正大天晴药业集团股份有限公司 | 针对PD-1和TGF-β的双功能蛋白 |
| WO2023046037A1 (zh) | 2021-09-24 | 2023-03-30 | 正大天晴药业集团股份有限公司 | 抗cd40抗体及其用途 |
| WO2024193516A1 (zh) | 2023-03-17 | 2024-09-26 | 百奥泰生物制药股份有限公司 | 抗ox40抗体在治疗炎症或免疫性疾病中的应用 |
| EP4681731A1 (en) | 2023-03-17 | 2026-01-21 | Bio-Thera Solutions, Ltd. | Use of anti-ox40 antibody in treatment of inflammations or immune diseases |
| WO2025044937A1 (zh) | 2023-08-31 | 2025-03-06 | 正大天晴药业集团股份有限公司 | 靶向受体酪氨酸激酶样孤儿受体1的抗体及其应用 |